Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
Reports second quarter revenue of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(1.97)Reiterates plan to...
Vaccine
Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded July 30, 2026 Q2 sales growth of...
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
Ad hoc announcement pursuant to Art. 53 LR QUVIVIQ™ (daridorexant) sales reached CHF 91 million in H1 2026, up 62%...
Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan
Ember offers Japanese market pharmaceutical transportation solution integrating temperature control, visualization of transportation status and traceabilityLOS ANGELES, July 29, 2026...
Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada
Burlington, Ontario--(Newsfile Corp. - July 28, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("Rapid Dose" or "RDT"),...
NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial
SHELTON, CT / ACCESS Newswire / July 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Timeshifter Marks Circadian Awareness Day (24/7) with “Why Timing Matters in Healthcare”
New report highlights circadian timing and control as one of the most powerful, and most overlooked, opportunities in personalized medicineNEW...
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews Paris, July 24, 2026. Sanofi today...
As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
SHELTON, CT / ACCESS Newswire / July 22, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC
SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic...
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
FORT LAUDERDALE, FL / ACCESS Newswire / July 20, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical...
Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors
CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first...
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak Three...
Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.
Strong U.S. demand and new product launches drive first-half sales in Human PharmaNet sales reach EUR 15.8 billion, led by...
As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo
SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
In HelloNation, Pediatric Expert Dr. James Wapshare Explains What Parents Should Expect at a Newborn’s First Pediatric Visit
The article reviews key steps, guidance, and early care topics covered during a newborn's first medical appointment.GOSHEN, N.Y., July 9,...
In HelloNation, Pediatric Expert Dr. James Wapshare Explains What Parents Should Expect at a Newborn’s First Pediatric Visit
The article reviews key steps, guidance, and early care topics covered during a newborn's first medical appointment.GOSHEN, N.Y., July 9,...
Heatwave and Temperature Mapping: When record heat rhymes with record risk
In the face of heat peaks, Dickson helps safeguard your compliance.ADDISON, Ill., July 9, 2026 /PRNewswire/ -- Whether you manage...
Heatwave and Temperature Mapping: When record heat rhymes with record risk
In the face of heat peaks, Dickson helps safeguard your compliance.ADDISON, Ill., July 9, 2026 /PRNewswire/ -- Whether you manage...